The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

Clinical trial NCT00181142 · COMPLETED

Trial details

NCT number: NCT00181142
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Patients Active and Listed for Lung Transplantation

Start date: 1999-10-01
Primary completion: 2004-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.